Hypoglycemic Agents: all 3,927 studies that test it
Page 39 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.
- Insulin Glulisine in Diabetes Mellitus, Type 2CompletedNCT00174668Phase 3
- Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney DiseaseWithdrawnNCT00169923Phase 2/3
- Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of MetforminTerminatedNCT00169624Phase 3
- Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 DiabetesCompletedNCT00168519Not applicable
- The Impact of Rosiglitazone on Regression of AtherosclerosisSuspendedNCT00166803Not applicable
- Comparing Two Ways of Controlling Blood Sugar With Insulin in Patients Admitted to the Intensive Care UnitCompletedNCT00166491Not applicable
- Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational DiabetesWithdrawnNCT00160485Phase 4
- Metformin in Pregnant PCOS WomenCompletedNCT00159536Phase 3
- Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or InsulinTerminatedNCT00159211Not applicable
- A Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic MigraineCompletedNCT00158002Phase 2
- Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant PatientsStatus unknownNCT00155350Phase 4
- Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.CompletedNCT00154011Not applicable
- Relationship Between Topiramate Use and Ocular Angle StatusStatus unknownNCT00153699Phase 4
- Effects of Pioglitazone in Congenital Adrenal HyperplasiaCompletedNCT00151710Not applicable
- LANN-study: Lantus, Amaryl, Novorapid, Novomix StudyCompletedNCT00151697Phase 3
- Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling GlucoseCompletedNCT00150410Phase 3
- Safety and Efficacy Study of Adjunctive Rosiglitazone in the Treatment of Uncomplicated Falciparum MalariaCompletedNCT00149383Phase 1/2
- Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 PatientsTerminatedNCT00148850Phase 3
- Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic PatientsCompletedNCT00147836Not applicable
- Pioglitazone Treatment in Polycystic Ovary SyndromeCompletedNCT00145340Phase 4
- Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood VesselsCompletedNCT00143624Not applicable
- Placebo and Active Controlled Study of Rivoglitazone in Type 2 DiabetesCompletedNCT00143520Phase 2/3
- To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.CompletedNCT00143338Phase 2
- To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.CompletedNCT00143104Phase 2
- The Study of Atherosclerosis With Ramipril and RosiglitazoneCompletedNCT00140647Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNCT00138619Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT00138606Phase 3
- Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%CompletedNCT00138593Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesCompletedNCT00138580Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 DiabetesCompletedNCT00138567Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 DiabetesCompletedNCT00138554Phase 3
- Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00138541Phase 3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00138515Phase 3
- Insulin on Post Burn HypermetabolismCompletedNCT00137254Not applicable
- Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)CompletedNCT00135941Phase 3
- Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal InsulinCompletedNCT00135096Phase 3
- Variable Bolus Regimen 1-2-3 for Type 2 Diabetes MellitusCompletedNCT00135083Phase 3
- Hospital In-Patient Insulin StudyTerminatedNCT00135070Phase 4
- Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal InsulinCompletedNCT00135057Phase 3
- Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for ObesityCompletedNCT00134303Phase 4
- The Effects of Calorie Restriction With or Without Metformin on Weight and Insulin ResistanceCompletedNCT00134290Phase 4
- A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose ControlCompletedNCT00134147Phase 3
- Dose Comparison Study of Topiramate in Pediatric Subjects With Basilar/Hemiplegic MigraineCompletedNCT00131443Phase 2/3
- Effect of Sulodexide in Overt Diabetic NephropathyTerminatedNCT00130312Phase 4
- SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using Magnetic Resonance Imaging (MRI) End-PointsCompletedNCT00124826Phase 2
- Rosiglitazone Plaque StudyStatus unknownNCT00123227Phase 3
- Effect of Rosiglitazone on Peritoneal Cytokines in Women With EndometriosisWithdrawnNCT00121953Phase 2/3
- Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 DiabetesCompletedNCT00120536Phase 3
- Rosiglitazone Versus Theophylline in Asthmatic SmokersCompletedNCT00119496Phase 2/3
- Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-DiabetesCompletedNCT00118963Phase 4
- Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by DietCompletedNCT00118950Phase 4
- Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and DietCompletedNCT00118937Phase 4
- Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 DiabetesCompletedNCT00117780Phase 4
- TART - Troglitazone Atherosclerosis Regression TrialCompletedNCT00116545Phase 2/3
- A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion PumpCompletedNCT00115973Phase 1
- Use of Rosiglitazone in the Treatment of EndometriosisTerminatedNCT00115661Phase 2
- Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and AdolescentsCompletedNCT00115570Phase 3
- Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset SeizuresCompletedNCT00113815Phase 3
- A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese SubjectsCompletedNCT00112021Phase 2
- Effects of PN2034 in Insulin-Dependent Patients With Type 2 DiabetesCompletedNCT00110864Phase 2
- Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)CompletedNCT00110851Phase 2
- Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 DiabetesCompletedNCT00110240Phase 3
- Effects of Insulin Sensitizers in Subjects With Impaired Glucose ToleranceCompletedNCT00108615Phase 4
- Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusCompletedNCT00108004Phase 3
- Glucontrol Study: Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit PatientsCompletedNCT00107601Not applicable
- Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes MellitusCompletedNCT00107107Phase 3
- Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesCompletedNCT00106808Phase 3
- Comparison of Insulin Detemir With Insulin Glargine in Type 2 DiabetesCompletedNCT00106366Phase 3
- Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00106340Phase 3
- Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 DiabetesCompletedNCT00104182Phase 3
- Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00102466Phase 3
- Efficacy and Safety of Vildagliptin Compared to Gliclazide in Drug Naive Patients With Type 2 DiabetesCompletedNCT00102388Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNCT00101803Phase 3
- INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) StudyCompletedNCT00101751Phase 4
- Efficacy and Safety of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes and Mild HyperglycemiaCompletedNCT00101712Phase 3
- Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%CompletedNCT00101673Phase 3
- A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 DiabetesCompletedNCT00099957Phase 2
- Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesCompletedNCT00099944Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT00099931Phase 3
- Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNCT00099918Phase 3
- A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00099905Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00099892Phase 3
- Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 DiabetesCompletedNCT00099866Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 DiabetesCompletedNCT00099853Phase 3
- Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate TherapyCompletedNCT00099619Phase 3
- Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid CancerStatus unknownNCT00098852Phase 2
- Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 DiabetesCompletedNCT00097877Phase 3
- Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 DiabetesCompletedNCT00097279Phase 3
- Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 DiabetesCompletedNCT00097084Phase 3
- Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and AdolescentsCompletedNCT00097071Phase 3
- The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) TrialCompletedNCT00095654Phase 3
- NovoLog Observation Trial in Subjects With Type 1 and Type 2 DiabetesCompletedNCT00095446Phase 4
- Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 DiabetesCompletedNCT00095082Phase 3
- Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderWithdrawnNCT00084578Not applicable
- Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric PopulationCompletedNCT00071448Phase 3
- Study Of AVANDAMET® With Or Without Insulin In Type II Diabetes Mellitus Patients. AVANDAMET® is a Registered Trademark of the GSK Group of Companies.CompletedNCT00069836Phase 3
- Treatment of Infertility in Women With Polycystic Ovary SyndromeCompletedNCT00068861Phase 3
- A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II DiabeticsCompletedNCT00067951Phase 3
- Treatment of Self-Injurious Behavior in Individuals With Prader-Willi SyndromeCompletedNCT00065923Not applicable
- Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational DiabetesCompletedNCT00065130Phase 3